Search Page

1

Cite

Share

Antisense oligonucleotides extend survival and reverse decrement in muscle response in ALS models.

McCampbell A, Cole T, Wegener AJ, Tomassy GS, Setnicka A, Farley BJ, Schoch KM, Hoye ML, Shabsovich M, Sun L, Luo Y, Zhang M, Comfort N, Wang B, Amacker J, Thankamony S, Salzman DW, Cudkowicz M, Graham DL, Bennett CF, Kordasiewicz HB, Swayze EE, Miller TM. McCampbell A, et al. Among authors: salzman dw. J Clin Invest. 2018 Aug 1;128(8):3558-3567. doi: 10.1172/JCI99081. Epub 2018 Jul 16. J Clin Invest. 2018. PMID: 30010620 Free PMC article.

Cite

Share

2

Cite

Share

The Non-Coding RNA Journal Club: Highlights on Recent Papers-4.

Gautheret D, Taube JH, Mani SA, Santulli G, Cuerda-Gil D, Slotkin RK, Zhang B, Wang Y, Salzman DW, Weidhaas JB. Gautheret D, et al. Among authors: salzman dw. Noncoding RNA. 2016 Sep 21;2(3):9. doi: 10.3390/ncrna2030009. Noncoding RNA. 2016. PMID: 29657267 Free PMC article.

Cite

Share

3

Cite

Share

SNPing cancer in the bud: microRNA and microRNA-target site polymorphisms as diagnostic and prognostic biomarkers in cancer.

Salzman DW, Weidhaas JB. Salzman DW, et al. Pharmacol Ther. 2013 Jan;137(1):55-63. doi: 10.1016/j.pharmthera.2012.08.016. Epub 2012 Sep 3. Pharmacol Ther. 2013. PMID: 22964086 Free PMC article. Review.

Cite

Share

4

Cite

Share

miR-34 activity is modulated through 5'-end phosphorylation in response to DNA damage.

Salzman DW, Nakamura K, Nallur S, Dookwah MT, Metheetrairut C, Slack FJ, Weidhaas JB. Salzman DW, et al. Nat Commun. 2016 Mar 21;7:10954. doi: 10.1038/ncomms10954. Nat Commun. 2016. PMID: 26996824 Free PMC article.

Cite

Share

5

Cite

Share

Estrogen withdrawal, increased breast cancer risk and the KRAS-variant.

McVeigh TP, Jung SY, Kerin MJ, Salzman DW, Nallur S, Nemec AA, Dookwah M, Sadofsky J, Paranjape T, Kelly O, Chan E, Miller N, Sweeney KJ, Zelterman D, Sweasy J, Pilarski R, Telesca D, Slack FJ, Weidhaas JB. McVeigh TP, et al. Among authors: salzman dw. Cell Cycle. 2015;14(13):2091-9. doi: 10.1080/15384101.2015.1041694. Epub 2015 May 11. Cell Cycle. 2015. PMID: 25961464 Free PMC article.

Cite

Share

6

Cite

Share

miRNAs in the spotlight: Making 'silent' mutations speak up.

Salzman DW, Weidhaas JB. Salzman DW, et al. Nat Med. 2011 Aug 4;17(8):934-5. doi: 10.1038/nm0811-934. Nat Med. 2011. PMID: 21818091 No abstract available.

Cite

Share

7

Cite

Share

Erratum: The Non-Coding RNA Journal Club: Highlights on Recent Papers-4. Non-Coding RNA 2016, 2, 9.

Gautheret D, Taube JH, Mani SA, Santulli G, Cuerda-Gil D, Slotkin RK, Zhang B, Wang Y, Salzman DW, Weidhaas JB. Gautheret D, et al. Among authors: salzman dw. Noncoding RNA. 2016 Sep 30;2(4):10. doi: 10.3390/ncrna2040010. Noncoding RNA. 2016. PMID: 29657269 Free PMC article.

Cite

Share

8

Cite

Share

The 5' terminal uracil of let-7a is critical for the recruitment of mRNA to Argonaute2.

Felice KM, Salzman DW, Shubert-Coleman J, Jensen KP, Furneaux HM. Felice KM, et al. Among authors: salzman dw. Biochem J. 2009 Aug 13;422(2):329-41. doi: 10.1042/BJ20090534. Biochem J. 2009. PMID: 19508234 Free PMC article.

Cite

Share

9

Cite

Share

P68 RNA helicase unwinds the human let-7 microRNA precursor duplex and is required for let-7-directed silencing of gene expression.

Salzman DW, Shubert-Coleman J, Furneaux H. Salzman DW, et al. J Biol Chem. 2007 Nov 9;282(45):32773-9. doi: 10.1074/jbc.M705054200. Epub 2007 Aug 27. J Biol Chem. 2007. PMID: 17724023 Free article.

Cite

Share

10

Cite

Share

A let-7 microRNA-binding site polymorphism in KRAS predicts improved outcome in patients with metastatic colorectal cancer treated with salvage cetuximab/panitumumab monotherapy.

Saridaki Z, Weidhaas JB, Lenz HJ, Laurent-Puig P, Jacobs B, De Schutter J, De Roock W, Salzman DW, Zhang W, Yang D, Pilati C, Bouché O, Piessevaux H, Tejpar S. Saridaki Z, et al. Among authors: salzman dw. Clin Cancer Res. 2014 Sep 1;20(17):4499-4510. doi: 10.1158/1078-0432.CCR-14-0348. Clin Cancer Res. 2014. PMID: 25183481 Free PMC article.

Cite

Share